Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112165833 | 11216583 | 3 | F | 20160726 | 20150624 | 20160804 | EXP | IT-AMGEN-ITASP2015059076 | AMGEN | M CARPENDO, S CANTONI, V COCCINI, ET AL. RESPONSE LOSS AND DEVELOPMENT OF NEUTRALIZING ANTIBODIES DURING LONG-TERM TREATMENT WITH ROMIPLOSTIM IN PATIENTS WITH IMMUNE TH ROM BOCYTOPENIA (ITP): A CASE SERIES. EUROPEAN JOURNAL OF HAEMATOLOGY. 2015;97:101-103 | 38.00 | YR | A | F | Y | 0.00000 | 20160803 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112165833 | 11216583 | 1 | PS | NPLATE | ROMIPLOSTIM | 1 | Unknown | 2 MUG/KG, UNK | 125268 | 2 | UG/KG | UNKNOWN FORMULATION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112165833 | 11216583 | 1 | Immune thrombocytopenic purpura |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112165833 | 11216583 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112165833 | 11216583 | Neutralising antibodies positive | |
| 112165833 | 11216583 | Therapeutic response decreased | |
| 112165833 | 11216583 | Therapy non-responder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |